aHUS-Interpretation is Complex

Article No. 433 9 May 2021 Each day there are tweets about aHUS on Twitter. Mostly clinicians informing clinicians about new articles on the subject. Recently two tweets were noticed…

Continue Reading aHUS-Interpretation is Complex

Atypical HUS & the Teen Years

Families with teenagers diagnosed with the life-threatening & rare disease atypical HUS deal with more than the usual host of everyday tangles regarding issues involving school, personal development, friendships, and activities.

Continue Reading Atypical HUS & the Teen Years

aHUS and COVID 19 Vaccine Update Update

Article No. 424 19 March 2021 COVID 19 vaccine supplies are being hampered around the world because of uncertainty about a causual link to some blood clotting following vaccination. There…

Continue Reading aHUS and COVID 19 Vaccine Update Update

aHUS uncertainty is a certainty

Article No. 423 16 March 2021 Update: Seven days after this news blog was published a further report on the ravulizumab trial was published ( see copy here ). 4 more…

Continue Reading aHUS uncertainty is a certainty

Eculizumab withdrawal risk profiling

Article No. 398 4 December 2020 In its previous article "Dip into ASH 2020" Global Action highlighted research results relating to "aHUS" and "TMA" which are to be presented at…

Continue Reading Eculizumab withdrawal risk profiling

Dip into ASH 2020

Article No. 397 28 November 2020   The second major conference at this time of year with research results which matter to aHUS patients is the  American Society of Hematologists'…

Continue Reading Dip into ASH 2020